Plant-based compounds could treat chronic pain in Parkinson’s, study finds

News

Author: Sophie BatesPublished: 12 March 2020

Prep: Cook: Serves:

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds.

The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s.

Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s.

“Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”

To read more on this topic click here.

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Special reports

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Second Life: a (virtual) world without Parkinson’s

Michael J Fox on his Parkinson’s: “Acceptance isn’t resignation”

MJ Fox and Todd Sherer interviewed for Google talks series

Billy Connolly: “Parkinson’s is the first thing I think about in the morning”

Scottish comedian opens up about his Parkinson’s awards ceremony

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

Could a specialised smartwatch support people with Parkinson’s disease?

A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

News

Author: Sophie BatesPublished: 12 March 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Special reports

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Perspectives

Michael J Fox on his Parkinson’s: “Acceptance isn’t resignation”

Perspectives

Billy Connolly: “Parkinson’s is the first thing I think about in the morning”

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

Plant-based compounds could treat chronic pain in Parkinson’s, study finds

News

Author: Sophie BatesPublished: 12 March 2020

Last Month

Next Month

Share this story

Comments

Related articles

Special reports

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Perspectives

Michael J Fox on his Parkinson’s: “Acceptance isn’t resignation”

Perspectives

Billy Connolly: “Parkinson’s is the first thing I think about in the morning”

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

Sign in